Medirom Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Medirom Healthcare Technologies
MRM Stock  USD 0.95  0.02  2.15%   
Medirom Healthcare financial statements provide useful quarterly and yearly information to potential Medirom Healthcare Technologies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Medirom Healthcare financial statements helps investors assess Medirom Healthcare's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Medirom Healthcare's valuation are summarized below:
Gross Profit
1.6 B
Profit Margin
0.0169
Market Capitalization
7.3 M
Enterprise Value Revenue
0.6383
Revenue
6.8 B
There are over one hundred nineteen available fundamental ratios for Medirom Healthcare, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check Medirom Healthcare's last-minute fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 23rd of January 2025, Market Cap is likely to grow to about 5.8 B, while Enterprise Value is likely to drop about 7.7 B.

Medirom Healthcare Total Revenue

5.48 Billion

Check Medirom Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medirom Healthcare's main balance sheet or income statement drivers, such as Interest Income of 2 M, Depreciation And Amortization of 305 M or Interest Expense of 44.5 M, as well as many indicators such as Price To Sales Ratio of 1.39, Dividend Yield of 0.0 or PTB Ratio of 18.66. Medirom financial statements analysis is a perfect complement when working with Medirom Healthcare Valuation or Volatility modules.
  
Check out the analysis of Medirom Healthcare Correlation against competitors.

Medirom Healthcare Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.3 B7.9 B5.3 B
Slightly volatile
Short and Long Term Debt Total2.9 B4.2 B2.9 B
Pretty Stable
Other Current Liabilities1.6 B1.9 B1 B
Slightly volatile
Total Current Liabilities3.2 B4.1 B2.7 B
Slightly volatile
Other Liabilities832.5 M1 B727.3 M
Slightly volatile
Property Plant And Equipment Net2.4 B2.9 B2.3 B
Slightly volatile
Current Deferred Revenue287.1 M460.8 M442.5 M
Slightly volatile
Net Debt2.3 B4.1 B2.5 B
Very volatile
Accounts Payable166.3 M158.4 M147.6 M
Pretty Stable
Cash90.9 M95.7 M320.5 M
Pretty Stable
Non Current Assets Total4.5 B5.9 B4 B
Slightly volatile
Non Currrent Assets Other749.7 M956.5 M905.2 M
Very volatile
Other Assets682 M969.6 M1 B
Slightly volatile
Long Term Debt753.3 M1.2 B550.8 M
Slightly volatile
Cash And Short Term Investments91.4 M96.2 M345.3 M
Pretty Stable
Net Receivables476.9 M559.7 M609.8 M
Pretty Stable
Good Will351.5 M557.2 M208.6 M
Slightly volatile
Common Stock Total Equity740.5 M1.4 B601 M
Slightly volatile
Common Stock Shares Outstanding5.4 M5.9 M4.9 M
Slightly volatile
Short Term Investments427.5 K450 K24.8 M
Slightly volatile
Liabilities And Stockholders Equity6.3 B7.9 B5.3 B
Slightly volatile
Non Current Liabilities Total2.9 B3.5 B2.5 B
Slightly volatile
Capital Lease Obligations2.1 B2.4 B2.1 B
Very volatile
Inventory169 M161 M42.1 M
Slightly volatile
Other Current Assets1.1 B1 B317.1 M
Slightly volatile
Other Stockholder Equity120.8 M127.2 M490.7 M
Pretty Stable
Total Liabilities6.1 B7.6 B5.3 B
Slightly volatile
Net Invested Capital1.2 B2 B940.4 M
Slightly volatile
Long Term Investments46.9 M93.8 M50.8 M
Pretty Stable
Property Plant And Equipment Gross2.3 B3.3 B2.3 B
Pretty Stable
Short and Long Term Debt235.8 M450.4 M360.3 M
Slightly volatile
Total Current Assets1.8 B2 B1.3 B
Slightly volatile
Capital Stock21.9 M23 M405.7 M
Pretty Stable
Non Current Liabilities Other182 M312.5 M96.5 M
Slightly volatile
Short Term Debt827.8 M1.1 B1.1 B
Slightly volatile
Intangible Assets1.1 B1.1 B296.7 M
Slightly volatile
Common Stock21.9 M23 M405.7 M
Pretty Stable
Property Plant Equipment1.7 B2 B2.2 B
Slightly volatile
Deferred Long Term Liabilities46 M51.8 M56.4 M
Slightly volatile

Medirom Healthcare Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income2 M1.3 M1.3 M
Slightly volatile
Depreciation And Amortization305 M290.5 M105.7 M
Slightly volatile
Interest Expense44.5 M42.4 M19.5 M
Slightly volatile
Selling General Administrative1.4 B2.1 B1.1 B
Slightly volatile
Total Revenue5.5 B7.9 B4.4 B
Slightly volatile
Gross Profit1.3 B1.8 B1.1 B
Slightly volatile
Other Operating Expenses5.7 B8.3 B4.5 B
Slightly volatile
Cost Of Revenue4.2 B6 B3.3 B
Slightly volatile
Total Operating Expenses1.5 B2.3 B1.2 B
Slightly volatile
Reconciled Depreciation305 M290.5 M102.3 M
Slightly volatile
Selling And Marketing Expenses128.6 M186.3 M101.2 M
Slightly volatile
Research Development10.8 M12.1 M13.2 M
Slightly volatile

Medirom Healthcare Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow616.9 M696.3 M404.2 M
Slightly volatile
Depreciation305 M290.5 M104.1 M
Slightly volatile
Capital Expenditures94.1 M156.2 M72.8 M
Slightly volatile
End Period Cash Flow90.9 M95.7 M320.5 M
Pretty Stable
Change To Netincome369.5 M351.9 M141.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.390.71.7435
Slightly volatile
Days Sales Outstanding21.3529.9228.2588
Slightly volatile
Stock Based Compensation To Revenue0.03440.03270.0156
Slightly volatile
Capex To Depreciation0.750.620.7272
Pretty Stable
EV To Sales1.771.32.2064
Slightly volatile
Inventory Turnover41.0443.21298
Slightly volatile
Days Of Inventory On Hand9.188.742.985
Slightly volatile
Payables Turnover21.9934.3722.5924
Slightly volatile
Sales General And Administrative To Revenue0.210.240.2586
Slightly volatile
Capex To Revenue0.01180.01790.0124
Slightly volatile
Cash Per Share22.623.7976.038
Pretty Stable
Days Payables Outstanding16.510.9917.759
Slightly volatile
Intangibles To Total Assets0.190.180.0777
Slightly volatile
Current Ratio0.450.440.4648
Slightly volatile
Receivables Turnover16.0512.6313.3288
Slightly volatile
Graham Number197129157
Slightly volatile
Capex Per Share12.723.6711.8573
Slightly volatile
Revenue Per Share8231.2 K875
Slightly volatile
Interest Debt Per Share386642467
Slightly volatile
Debt To Assets0.320.480.4297
Slightly volatile
Operating Cycle24.3338.6630.8563
Very volatile
Days Of Payables Outstanding16.510.9917.759
Slightly volatile
Long Term Debt To Capitalization1.020.961.2331
Slightly volatile
Total Debt To Capitalization0.760.850.9851
Slightly volatile
Quick Ratio0.610.520.4732
Slightly volatile
Net Income Per E B T5.275.021.6867
Slightly volatile
Cash Ratio0.03260.03430.1224
Very volatile
Cash Conversion Cycle31.5630.0614.7298
Slightly volatile
Days Of Inventory Outstanding9.188.742.985
Slightly volatile
Days Of Sales Outstanding21.3529.9228.2588
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.741.090.8423
Slightly volatile
Fixed Asset Turnover1.782.421.8503
Slightly volatile
Debt Ratio0.320.480.4297
Slightly volatile
Price Sales Ratio1.390.71.7435
Slightly volatile
Asset Turnover0.690.90.7998
Slightly volatile
Gross Profit Margin0.260.22980.2603
Slightly volatile

Medirom Healthcare Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.8 B4.8 B6.6 B
Slightly volatile
Enterprise Value7.7 B8.9 B8.5 B
Slightly volatile

Medirom Fundamental Market Drivers

Cash And Short Term Investments106.8 M

Medirom Upcoming Events

29th of May 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Medirom Healthcare Financial Statements

Medirom Healthcare investors utilize fundamental indicators, such as revenue or net income, to predict how Medirom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue460.8 M287.1 M
Total Revenue7.9 B5.5 B
Cost Of Revenue6 B4.2 B
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.24  0.21 
Capex To Revenue 0.02  0.01 
Revenue Per Share1.2 K823
Ebit Per Revenue(0.07)(0.07)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
How To Invest In Medirom
Details
Is Medirom Stock a good investment?
Details
What is Medirom Healthcare's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Medirom Healthcare Correlation against competitors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.582
Earnings Share
(0.15)
Revenue Per Share
1.4 K
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.04)
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY